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Background. Data from the largest randomized, controlled trial for the treatment of children hospitalized with
severe malaria were used to identify such predictors of a poor outcome from severe malaria.
Methods. African children (,15 years) with severe malaria participated in a randomized comparison of
parenteral artesunate and parenteral quinine in 9 African countries. Detailed clinical assessment was performed on
admission. Parasite densities were assessed in a reference laboratory. Predictors of death were examined using
a multivariate logistic regression model.
Results. Twenty indicators of disease severity were assessed, out of which 5 (base deficit, impaired
consciousness, convulsions, elevated blood urea, and underlying chronic illness) were associated independently
with death. Tachypnea, respiratory distress, deep breathing, shock, prostration, low pH, hyperparasitemia, severe
anemia, and jaundice were statistically significant indicators of death in the univariate analysis but not in the
multivariate model. Age, glucose levels, axillary temperature, parasite density, heart rate, blood pressure, and
blackwater fever were not related to death in univariate models.
Conclusions. Acidosis, cerebral involvement, renal impairment, and chronic illness are key independent
predictors for a poor outcome in African children with severe malaria. Mortality is markedly increased in cerebral
malaria combined with acidosis.
Clinical Trial Registration. ISRCTN50258054.
Falciparum malaria can progress rapidly from an
uncomplicated febrile illness that usually resolves with
oral medication to a potentially lethal multisystem
disease, despite in-hospital parenteral treatment. The
mortality risk in uncomplicated falciparum malaria is
thought to be under 0.1%, rising toward 1% as treat-
ments fail in the context of antimalarial drug resistance
[1]. The mortality due to severe malaria in young chil-
dren usually exceeds 10% and increases with age [2].
Several predictive factors for death in severe child-
hood malaria have been identified [3]; among them,
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coma [2, 4–36], convulsions [2, 13, 18, 27, 29, 34, 36–42],
acidosis [2, 5, 6, 8–10, 12, 14, 17, 21, 22, 25, 30, 31, 34,
42–51], respiratory distress [6–9, 12, 19, 26, 30, 31, 35, 38, 39, 41,
45, 46, 50–58], hypoglycemia [7, 10, 14, 16, 18, 20, 25, 27, 37,
41, 47], retinal changes [4, 11, 15, 25, 28, 29, 38, 59–61], in-
creased concentrations of lactate in blood and cerebrospinal
fluid [18, 62–64], increased concentrations of tumor necrosis
factor [65–69], and the presence of malarial pigment in 0.5% or
more of peripheral blood neutrophils [70]. Combinations of
prognostic indicators or scoring systems have also been evaluated
to identify patients who have an increased risk of death [53, 57].
Outcomes in severe falciparum malaria depend on the
nature and degree of vital organ dysfunction. This differs
between adults and children. For example, severe malaria with
renal failure is an important cause of death in adults but acute
renal failure from malaria-induced acute tubular necrosis is rare
in children from any cause and is very rarely reported in African
children with severe malaria [2, 53, 71, 72]. In contrast, severe
anemia is a very common presentation of severe malaria in
young children in high-transmission settings, but is relatively
unusual in adults. Universal indicators can be used in clinical
trials to define severe malaria, and can also direct studies of the
pathogenesis of severe malaria and guide the identification of
new targets for intervention. Using data from the largest severe
malaria treatment trial to date [73], we analyzed the relationship
between clinical and laboratory characteristics collected on ad-
mission and the risk of death.
METHODS
This analysis is based on a randomized clinical trial compar-
ing parenteral artesunate with parenteral quinine in African
children with severe falciparum malaria [73]. The trial was
conducted between 2005 and 2010 in 11 participating centers
in 9 African countries (Table 1). The spectrum of partici-
pating hospitals ranged from university hospitals and re-
search institutes to rural hospitals without prior research
experience. Human immunodeficiency virus (HIV) testing
was approved at 4 sites (Beira, Muheza, Rwamagana/Nyanza,
and Kilifi). The reported HIV prevalence (Table 1) relied on
historical data from adults [74].
The methods and the outcome of the trial have been re-
ported in detail elsewhere [73]. Febrile children less than
15 years of age with a positive Plasmodium falciparum histidine-
rich protein 2–based rapid test (Optimal) for falciparum
malaria were eligible for enrolment based on a clinical judg-
ment of severe malaria, which included at least 1 of the fol-
lowing conditions: coma, defined by a Blantyre Coma Scale
(BCS) score#2 for children less than 2 years of age or a Glasgow
Coma Scale (GSC) score #9 for older children; prostration,
defined as the inability to sit unsupported (for children over
6 months of age) or the inability to drink or breast-feed in
younger children; convulsions with a duration longer than
30 minutes or a frequency of 2 or more in the 24 hours
preceding admission; compensated shock, defined as a periph-
eral capillary refill time $3 seconds or the presence of a tem-
perature gradient with a normal systolic BP ($70 mmHg);
decompensated shock, defined as a systolic blood pressure
,70 mmHg; severe respiratory distress, defined as nasal alar
flaring, costal indrawing, or use of accessory muscles, severe
tachypnea, or deep breathing; hypoglycemia, defined as blood
glucose ,3 mmol/L or clinical improvement in the level of
consciousness immediately after administration of 10% dex-
trose; severe symptomatic anemia, defined as severe pallor
combined with respiratory distress; blackwater fever; clinical
jaundice; hyperparasitemia, defined as asexual parasitemia
Table 1. Age Distribution, Case Fatality Rate, and Adult HIV Prevalence by Study Center
Study Center
Number of
Children
Median Age
(IQR, Years) Mortality (%)
HIV/AIDS Adult
Prevalence Rate (%) [78]
Banjul, The Gambia 502 4.4 (3.0, 6.1) 55 (11%) 1
Beira, Mozambique 664 3.8 (2.5, 5.3) 75 (11%) 12
Ilorin, Nigeria 450 2.8 (1.8, 4.2) 41 (9%) 3
Rwamagana and Nyanza, Rwanda 271 and 115 3.3 (1.7, 5.1) 20 (5%) 2
Kilifi, Kenya 442 3.3 (2.3, 4.8) 44 (10%) 8
Kinshasa, DRC 422 2.4 (1.6, 4.2) 18 (4%) 4
Korogwe, Tanzania 540 2.3 (1.3, 3.5) 80 (15%) 8
Kumasi, Ghana 436 3.0 (2.0, 4.3) 21 (5%) 1
Mbarara, Uganda 663 1.8 (1.0, 2.8) 42 (6%) 4
Teule, Tanzania 921 2.2 (1.2, 3.3) 131 (14%) 8
Total 5426 2.8 (1.7, 4.3) 527 (10%) 6a
Abbreviations: DRC, Democratic Republic of the Congo; HIV, human immunodeficiency virus; IQR, interquartile range.
a Weighted mean.
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above 10%. Patients were enrolled after a relative or guardian
gave informed written consent.
Definitions of Clinical Features on Presentation
Seizures were defined as a history of convulsion of 30 minutes
or longer reported by the caregiver or observed by the health
care provider. On admission, the axillary temperature was
measured with a digital thermometer, and the respiratory rate
was recorded. Coma, respiratory distress, deep breathing, and
shock were defined as stated in the inclusion criteria [56].
Blood pressure was measured using a digital sphygmoma-
nometer. The presence of lymphadenopathy, candidiasis,
nuchal rigidity, visible severe wasting, and edematous mal-
nutrition were noted following standard guidelines [75].
Baseline Laboratory Results
A venous blood sample was collected for malaria rapid di-
agnostic tests, thin and thick blood films, and a point-of-care
assessment of standard base excess (BE), negative logarithm of
the blood hydrogen ion concentration (pH), glucose, blood
urea nitrogen (BUN), hematocrit (HCT), and hemoglobin
(Hb) using an automated handheld blood analyzer (i-STAT,
Abbott Laboratories, Abbott Park, IL). In total, 419 i-STAT
results were excluded from the analysis because of instrument
malfunction. The blood films were read at the reference lab-
oratory at the Mahidol Oxford Research Unit in Bangkok.
Malaria parasites were quantified using the readings from the
thin blood film, or if not available, calculated from the thick
blood film (40 3 count/200 white blood cells).
Statistical Analysis
The univariate association between various clinical indictors
and mortality from severe malaria was initially examined
visually using box plots and histograms. Factors that were
considered potential independent predictors of mortality
were recorded at admission, and are included in (Table 2).
Lymphadenopathy, malnutrition, candidiasis, severe visible
wasting, and desquamation were combined into a single
variable as an indicator of chronic disease, which was also
examined as a risk factor. Compensated shock and decom-
pensated shock were also combined into a single variable.
The BCS scores (used for preverbal children; n 5 3417) and
the GCS scores (n 5 2004) were combined into a single
coma score (1–5). In Rwanda, 2 smaller sites (Rwamagana
and Nyanza), run by the same investigators, were combined.
The P values for the univariate analysis were derived by
logistic regression analysis, stratified by site, and adjusted
for treatment. Correlations between variables were evalua-
ted using Spearman’s rank correlation coefficients or the
2-sample Wilcoxon rank-sum (Mann-Whitney) test.
The prognostic importance of these admission variables
was assessed in a multivariate logistic regression model.
All clinical indicators that were significant in the univariate
analysis were included in the model, with death as the de-
pendent variable. A priori specified interactions between
respiratory rate and shock, respiratory rate and age, res-
piratory rate and base excess, and base excess and age were
assessed. A visual examination of the univariate associations
between the clinical factors and death indicated possible
nonlinear associations with some of the continuous variables
(eg, glucose, log parasitemia, and respiratory rate; Figure 1).
Therefore, multivariable fractional polynomials were used
in conjunction with logistic regression to identify the model
that would best predict the outcome [76]. Fractional poly-
nomials indicated that the best fitting final model was ach-
ieved with linear values. Because a large set of potential
predictors was compared, there was a risk that at least 1
indicator would reach the .05 level of significance purely by
chance [77]. Hence, only variables with a P value less than
.01 were retained in the final model, which was also adjusted
for treatment (artesunate or quinine) and stratified by site.
Receiver operating characteristic (ROC) analysis was used to
evaluate the prediction ability of the final model. The logistic
regression models made use of continuous variables. The fit of
multivariate regression models was compared using likelihood
Table 2. Indicators Evaluateda
1. Age (years)
2. Base excess (BE, mmol/L)
3. Blackwater fever/dark urine
4. Coma score based on the Blantyre Coma Scale (BCS; 0–5) or
Glasgow Coma Scale (GCS; 3–15)
5. Blood urea nitrogen (BUN, mg/dL)
6. Chronic disease (candidiasis, lymphadenopathy, malnutrition,
severe visible wasting, desquamation of skin)
7. Convulsions (30 min or longer or $2 convulsions in 24 h
preceding admission)
8. Glucose (mg/dL)
9. Hemoglobin (g/dL)
10. Heart rate (beats/min)
11. Log parasitemia (lL)
12. pH
13. Prostration (unable to sit unsupported; if under 6 months old,
unable to breastfeed)
14. Respiratory distress (severe tachypnea, nasal alar flaring, costal
indrawing or use of accessory muscles)
15. Deep breathing (labored breathing pattern with abnormally
deep chest excursions)
16. Respiratory rate (breaths/min)
17. Sex
18. Shock (compensated and decompensated)
19. Systolic blood pressure (mmHg)
20. Axillary temperature (oC)
21. Visible jaundice
a Alphabetical order.
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ratios and Wald tests. In the Venn diagram approach, children
with a combined coma score ,3 were considered comatose,
with a BE less than28 mmol/L as acidotic, and with a BUN equal
or larger than 20 mg/dL as uremic. All analyses were performed
using Stata software, version 11 (StataCorp, College Station, TX).
Ethical Review
The trial protocol was approved by each local ethical review
board, the Oxford Tropical Research Ethics committee, and the
Institutional Review Board of the London School of Hygiene
and Tropical Medicine.
RESULTS
There were 5426 children ,15 years of age that participated
in the study at 11 sites, of whom 9.7% (527) died (Table 1).
Thirteen of the 21 variables examined were significantly as-
sociated with death in univariate models and were included
in the multivariate model (Tables 3 and 4, Figure 1). The
final model was fitted with data from 4089 children. The case
fatality rate of children included and excluded from the
model was 9.8%. There were 5 highly significant indepen-
dent predictors of mortality from severe malaria in children,
Figure 1. Baseline distribution of continuous variables in relation to outcome: survival or death.
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including base deficit (adjusted odds ratio [AOR] 1.12, 95%
confidence interval (CI) 1.10–1.13), coma score (AOR 1.40,
95% CI 1.34–1.45), convulsions (AOR 1.72, 95% CI 1.30–2.30),
BUN (AOR 1.02, 95% CI 1.02–1.03), and chronic illness
(AOR 2.12, 95% CI 1.25–3.58). The area under the ROC
curve indicated good ability of the model to predict mor-
tality (area 5 85%, 95% CI 83–87). None of the investigated
interaction terms (respiratory rate and shock, respiratory
rate, and age, respiratory rate and base excess, or base excess
and age) were statistically significant. One or more of the
independently significant variables from the final model
were present at admission in 391/401 (98%) of children who
died. There were 9 of 1065 (1%) children without any of po-
tential risk factors on admission who died, in contrast to 66
of 124 (53%) children with 4 predictors (Table 5). In a Venn
diagram that incorporates the 3 most frequent, independently
statistically significant predictors, acidosis (BE , 28 mmol/L),
impaired consciousness (combined coma score ,3) or con-
vulsions, and elevated blood urea (.20 mg/dL), the estimated
mortality in children with all 3 predictors was 43% (Figure 2).
In children with acidosis and impaired consciousness, the
mortality was 23%. The sensitivity of acidosis as a prognostic
indicator for death in this cohort was 78% (specificity 96%),
impaired consciousness was 66% (specificity 95%), and elevated
Figure 1 continued.
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blood urea was 53% (specificity 95%). If 2 of the 3 prognostic
signs (acidosis, impaired consciousness, or elevated blood urea)
were detected, the sensitivity increased to 94% (specificity 98%).
Specific Predictors
Acidosis
Increasing levels of acidosis were associated with increasing
mortality (Table 3). The mean (SD) BE on admission among
the 413 children who died was 216 mmol/L (8.1) compared
with 28 mmol/L (6.5) among the 3784 survivors (P , .001).
Similarly, there was a statistically significant difference be-
tween the mean pH (SD) of the 413 children who died
(pH 5 7.25, 0.19) and the 3782 children who survived
(pH 5 7.38, 0.11; P , .001). When BE and pH were in-
cluded in multivariate models, BE but not pH remained an
independent and statistically significant covariable.
Impaired Consciousness and Cerebral Malaria
Mortality increased with decreasing coma scores. Of the of
children with a combined coma score #2, 21% (347/1645)
died in contrast to 5% (178/3777) of the remaining children
(P , .001). Of the children who experienced convulsions,
14% (242/1692) died in contrast to 8% (285/3734) of the
remaining children (P , .001). The coma score retained
statistical significance in the multivariate model.
Blood Urea Nitrogen
Mortality increased with increasing BUN in the study pop-
ulation. The median BUN was 24 mg/dL among the 409
children who died and 15 mg/dL among the 3739 children
who survived (P , .001). There was a statistically significant
but weak correlation between increasing age of children and
increasing BUN (Spearman q 5 0.08; P , .001).
Underlying Chronic Illnesses
Clinical signs of an underlying chronic illness was observed in
189 (4%) of the 5379 children participating in the study.
Lymphadenopathy on its own was associated with high mor-
tality (21%; 17/82 compared with 9%; 504/5312; P , .001)
but was not statistically significant in multivariate models.
A combined variable representing signs of chronic illness was
associated with a high mortality of 18% (34/189) compared
with 9% (486/5190; P , .001) for separate variables, and the
combined variable retained statistical significance in the
multivariate model.
Respiration
The respiratory rate was significantly higher (Figure 1), and
respiratory distress (Table 4) and deep breathing were sig-
nificantly more frequently encountered in children who died
than in children who survived. In a multivariate model,
which included a base deficit, none of the clinical signs re-
lated to respiration were independently significant. There
was a significant correlation between respiratory distress
(P , .001), respiratory rate (q 5 –0.3; P , .001), deep breath-
ing (P , .001), and base deficit. In a model without a base
deficit, deep breathing and respiratory rate were significant;
however, the model that included a base deficit had a sig-
nificantly better fit (likelihood ratio test P , .0001).
Table 3. Association Between Childhood Severe Malaria Clinical Markers With Death: Continuous Variablesa
Died Survived
Risk factor n Mean (SD) or median (IQR)b n Mean (SD) or median (IQR)b P c
BE, mmol/L 413 215.6 (8.1) 3784 -7.8 (6.5) ,.001
pH 413 7.25 (0.19) 3782 7.38 (0.11) ,.001
Coma scored 525 2.2 (1.6) 4897 3.7 (1.5) ,.001
BUN, mg/dL 409 23.9 (17.2) 3739 14.9 (11.6) ,.001
Respiratory rate, breaths/min 517 52.6 (14.6) 4879 46.8 (14.1) ,.001
Hemoglobin, mg/dL 449 6.6 (3.0) 4052 7.0 (2.9) ,.001
Heart rate, beats/min 515 148.5 (32.2) 4878 144.3 (28.1) .03
Age, years (median) 527 2.5 (1.5–4.1) 4899 2.8 (1.7–4.3) .06
Axillary temperature, oC 521 38.1 (1.2) 4885 38.0 (1.1) .24
Glucose, mg/dL 444 117 (97.4) 3994 120 (71.1) .35
Systolic blood pressure, mmHg 403 94.5 (17.3) 3886 94.8 (15.5) .67
Parasite density/lLe 450 45 533 (16–1 858 880) 4321 45 232 (16–1 251 227) .82
Abbreviations: BE, base excess; BUN, blood urea nitrogen; IQR, interquartile range; SD, standard deviation.
a Sorted by P value.
b Unless otherwise specified.
c From logistic regression analysis, stratified by site and adjusted for treatment.
d Blantyre Coma Scale and Glasgow Coma Scale scores were combined into 1 variable for analysis.
e Geometric mean (range).
Predicting Severe Falciparum Malaria Outcome d CID 2012:54 (15 April) d 1085
DISCUSSION
In this study, 4 predictors were independently associated with
an increased risk of death: acidosis indicated by a large base
deficit, cerebral manifestations of malaria (coma and/or con-
vulsions), an elevated blood urea nitrogen, or signs of chronic
illness on admission. The standard base deficit was found to
be the single most relevant predictor of death in this series,
which confirms findings from Malawian children [30] and adult
Asians [43] with severe malaria. In our study, the specificity of
impaired consciousness and acidosis were similar (95% vs 96%),
but the sensitivity of acidosis as a prognostic marker was 78%
compared with a sensitivity of 66% for impaired conscious-
ness. Deep breathing and respiratory distress also had high spe-
cificities (93% and 92%), but the sensitivity of deep breathing
was only 41% and that of respiratory distress was only 28%.
In severe malaria, sequestration of red blood cells con-
taining the mature parasites leads to tissue ischemia. Re-
duced red cell deformability, the clumping of uninfected to
infected red cells (rosetting), and the clumping between in-
fected red cells (auto-agglutination) further contribute to
the impairment of microcirculatory flow, causing tissue
hypoxia and a shift from aerobic to anaerobic metabolism.
With anaerobic metabolism, pyruvate is converted into lactic
acid, an important but not exclusive contributor to acidosis
[44, 78]. A venous blood base deficit had a stronger prog-
nostic value than pH, which has been confirmed in other
studies [43]. This is not surprising because a base deficit
better reflects metabolic acidosis, whereas the pH starts to
drop only when respiratory compensation is insufficient and
the blood’s buffering capacity becomes exhausted [78]. Be-
cause respiratory signs in severe malaria are a response to
acidosis, it should also not be surprising that respiratory
signs are not independently significant predictors in models
that include a base deficit. The sequestration of infected red
blood cells in the cerebral microvasculature is thought to be
the central pathological process preceding the cerebral
manifestations of severe malaria [18, 21]. Coma and con-
vulsions suggest advanced cerebral involvement, and deep
coma can progress to central respiratory depression followed
by death.
The association of an elevated BUN with poor outcome is of
interest, as renal involvement is rarely reported in children
[13, 35, 72] in contrast to adults with severe malaria [2, 53, 71].
The findings from this study suggest that renal involvement
could be frequently overlooked in children with severe ma-
laria. A number of factors can contribute to an increased
BUN, including hypovolemia and increased protein break-
down. More research is required to explore the significance
of elevated BUN in children with severe malaria.
Overall, 4% of the study participants were diagnosed with
chronic debilitating illness, the causes of which include a diverse
Table 4. The Association Between Childhood Severe Malaria
Clinical Markers With Death: Categorical Variables
Risk factor n Died (%) P a
Convulsions
Yes 1692 242 (14) ,.001
No 3734 285 (8) .
Prostration
Yes 2974 142 (5) ,.001
No 2452 385 (16) .
Shockb
Yes 663 123 (19) ,.001
No 4763 404 (9) .
Respiratory distress
Yes 867 145 (17) ,.001
No 4559 382 (8) .
Deep breathing
Yes 938 218 (23) ,.001
No 4488 309 (7) .
Jaundice
Yes 114 22 (19) ,.001
No 5312 505 (10) .
Chronic diseasec
Yes 189 34 (18) ,.001
No 5190 486 (9) .
Sex
Male 2815 275 (10) .74
Female 2611 252 (10) .
Blackwater fever
Yes 237 22 (9) .96
No 5189 505 (10) .
a From logistic regression analysis, stratified by site and adjusted for
treatment.
b Compensated and decompensated shock combined.
c Lymphadenopathy, malnutrition, candidiasis, severe visible wasting and
desquamation combined as an indicator for chronic disease.
Table 5. Score Based on 5 Independently Significant Variables:
Base Excess (<28 mmol/L), Blood Urea Nitrogen (‡ 20 mg/dL),
Combined Coma Score <3, Chronic Disease, and Convulsions.a
Score Survived Died (%) Total
0 1056 9 (1) 1065
1 1339 75 (5) 1414
2 923 118 (11) 1041
3 311 131 (30) 442
4 58 66 (53) 124
5 1 2 (67) 3
Total 3688 402 (10) 4089
a Presence of each variable provides 1 point to the score.
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spectrum of pathologies, including malnutrition and HIV
infection. It is likely that a proportion of the chronically de-
bilitated children were suffering from AIDS, but only 4 sites
conducted diagnostic tests for it. Increased morbidity and
mortality from severe malaria in HIV-infected children has
been reported previously [79, 80].
Independent of other factors, there was no association of
severe anemia with death in our study. This may be because
life-threatening severe anemia is accompanied by metabolic
acidosis and prostration. Furthermore, early transfusion in
life-threatening severe anemia in pediatric falciparum ma-
laria can prevent death [81]. In the current series, only those
children with extremely low hemoglobin concentrations
(,3 g/dL) were at an increased risk of dying. Similarly, hy-
poglycemia can be reversed when detected early, and as
a severity sign, it is, again, not independent of other severity
symptoms, including metabolic acidosis. Hyperparasitemia
has been associated with a poor outcome in severe malaria
[18]. In our cohort, only extremely high parasite densities
above 440 000/lL carried an increased risk of death. There
was a small group of 25 severely ill children who presented
with very low parasite densities, and the mortality in this
subgroup was also high (20%). It is possible that the malaria
in these children was not the primary cause of illness, but was
instead a coincidental coinfection. Very high mortality in
patients with malaria and bacteremia coinfections has been
documented [82–84].
We observed a lower mortality in children with prostration
(5%) compared with children without prostration (16%).
Cerebral impairment caused by malaria exhibits a wide
spectrum that consists of the relatively mild presentation of
prostration as compared with convulsions and coma, which
lie on the other end of this spectrum. Children whose pre-
sentation includes prostration have a lower mortality rate
compared with children who have a more advanced im-
pairment of their central nervous system, but have an in-
creased mortality compared with children with uncomplicated
malaria [1].
While the inclusion of a very large cohort from highly
heterogeneous settings assures the generalizability of the
findings, there is a risk that high interobserver variability
occurred. This could explain, at least in part, the relatively
poor performance of several clinical signs such as shock,
prostration, and respiratory distress as indicators for severity
in this study. It is reassuring that coma scales turned out to
be valid prognostic indicators. A limitation of our study is
the fact that not all participants in the trial had all test results
assessed. The major reason for missing results was the un-
availability of i-STAT results due to a malfunctioning ana-
lyzer or an interrupted supply of test cards.
Robust and locally affordable point-of-care tests to mea-
sure any base deficit would be highly desirable for the man-
agement of severe malaria patients in sub–Saharan Africa.
Until such diagnostic tests are widely available, clinical signs
Figure 2. Venn diagram illustrating the combinations of presentations and associated mortality.
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will have to suffice to guide clinicians. In the absence of
a diagnostic test for respiratory acidosis, deep breathing
signs can be a valuable marker for high risk patients in the
hands of skilled observers. For large, multicenter studies,
which employ observers with variable levels of training and
skills, a standardized test for acidosis seems preferable.
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